SBFM Relative Valuation
SBFM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SBFM is overvalued; if below, it's undervalued.
Historical Valuation
Sunshine Biopharma Inc (SBFM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.56. The fair price of Sunshine Biopharma Inc (SBFM) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：1.46
Fair
-2.92
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Sunshine Biopharma Inc. (SBFM) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.56
EV/EBIT
Sunshine Biopharma Inc. (SBFM) has a current EV/EBIT of 0.56. The 5-year average EV/EBIT is 0.95. The thresholds are as follows: Strongly Undervalued below -5.92, Undervalued between -5.92 and -2.49, Fairly Valued between 4.39 and -2.49, Overvalued between 4.39 and 7.82, and Strongly Overvalued above 7.82. The current Forward EV/EBIT of 0.56 falls within the Historic Trend Line -Fairly Valued range.
0.15
PS
Sunshine Biopharma Inc. (SBFM) has a current PS of 0.15. The 5-year average PS is 0.14. The thresholds are as follows: Strongly Undervalued below -0.32, Undervalued between -0.32 and -0.09, Fairly Valued between 0.37 and -0.09, Overvalued between 0.37 and 0.61, and Strongly Overvalued above 0.61. The current Forward PS of 0.15 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Sunshine Biopharma Inc. (SBFM) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Sunshine Biopharma Inc. (SBFM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Sunshine Biopharma Inc (SBFM) has a current Price-to-Book (P/B) ratio of 0.28. Compared to its 3-year average P/B ratio of 0.34 , the current P/B ratio is approximately -17.92% higher. Relative to its 5-year average P/B ratio of 0.20, the current P/B ratio is about 37.23% higher. Sunshine Biopharma Inc (SBFM) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -179.14%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -110.39% , the current FCF yield is about -100.00% lower.
0.27
P/B
Median3y
0.34
Median5y
0.20
-103.38
FCF Yield
Median3y
-179.14
Median5y
-110.39
Competitors Valuation Multiple
The average P/S ratio for SBFM's competitors is 0.00, providing a benchmark for relative valuation. Sunshine Biopharma Inc Corp (SBFM) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 11.64%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SBFM decreased by 52.00% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 8.44M to 9.42M.
The secondary factor is the P/E Change, contributed -29.77%to the performance.
Overall, the performance of SBFM in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Sunshine Biopharma Inc (SBFM) currently overvalued or undervalued?
What is Sunshine Biopharma Inc (SBFM) fair value?
How does SBFM's valuation metrics compare to the industry average?
What is the current P/B ratio for Sunshine Biopharma Inc (SBFM) as of Dec 05 2025?
What is the current FCF Yield for Sunshine Biopharma Inc (SBFM) as of Dec 05 2025?
What is the current Forward P/E ratio for Sunshine Biopharma Inc (SBFM) as of Dec 05 2025?